Literature DB >> 34345558

A Case of COVID-19-Associated Autoimmune Hemolytic Anemia With Hyperferritinemia in an Immunocompetent Host.

Zoha Huda1, Abdullah Jahangir2, Syeda Sahra3, Muhammad Rafay Khan Niazi3, Shamsuddin Anwar2, Allison Glaser4, Ahmad Jahangir5.   

Abstract

We report an interesting case of a middle-aged gentleman who presented with diabetic ketoacidosis (DKA) and tested polymerase chain reaction (PCR) positive for COVID-19 infection. His hospital stay was complicated by acute kidney injury, hematuria, and normocytic anemia. Initial chest x-ray demonstrated bibasilar opacities. D-dimer and C-reactive protein were elevated. During his hospital stay, his hemoglobin decreased from 13.4 g/dL to 9 g/dL, and further workup demonstrated ferritin of 49,081 ng/mL with lactate dehydrogenase of 1665 U/L. He was treated with prednisone and folic acid for autoimmune hemolytic anemia (AIHA). Ferritin was downtrended, and hemoglobin stabilized. As demonstrated by this case report and prior literature review, COVID-19 infection can be associated with AIHA.
Copyright © 2021, Huda et al.

Entities:  

Keywords:  autoimmune hemolytic anemia (aiha); covid-19; hemolytic anemia; high ferritin; hyperferritinemia

Year:  2021        PMID: 34345558      PMCID: PMC8324606          DOI: 10.7759/cureus.16078

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  22 in total

Review 1.  How I treat autoimmune hemolytic anemias in adults.

Authors:  Klaus Lechner; Ulrich Jäger
Journal:  Blood       Date:  2010-06-14       Impact factor: 22.113

2.  Hematologic autoimmune disorders in the course of COVID-19: a systematic review of reported cases.

Authors:  Erfan Taherifard; Ehsan Taherifard; Hamed Movahed; Mohammad Reza Mousavi
Journal:  Hematology       Date:  2021-12       Impact factor: 2.269

3.  COVID-19 and Autoimmune Diseases: A Systematic Review of Reported Cases.

Authors:  Mariam Ahmed Saad; Mostafa Alfishawy; Mahmoud Nassar; Mahmoud Mohamed; Ignatius N Esene; Amira Elbendary
Journal:  Curr Rheumatol Rev       Date:  2021

4.  COVID-19 presenting with autoimmune hemolytic anemia in the setting of underlying immune dysregulation.

Authors:  Lara Wahlster; Nina Weichert-Leahey; Maria Trissal; Rachael F Grace; Vijay G Sankaran
Journal:  Pediatr Blood Cancer       Date:  2020-06-03       Impact factor: 3.167

5.  Cold agglutinin disease and autoimmune hemolytic anemia with pulmonary embolism as a presentation of COVID-19 infection.

Authors:  Neha R Patil; Erica S Herc; Marian Girgis
Journal:  Hematol Oncol Stem Cell Ther       Date:  2020-07-06

Review 6.  Virus-induced autoimmune disease.

Authors:  M G von Herrath; M B Oldstone
Journal:  Curr Opin Immunol       Date:  1996-12       Impact factor: 7.486

7.  Methemoglobinemia and hemolytic anemia after COVID-19 infection without identifiable eliciting drug: A case-report.

Authors:  Desirée Verde Lopes; Felippe Lazar Neto; Lais C Marques; Rodrigo B O Lima; Antonio Adolfo Guerra Soares Brandão
Journal:  IDCases       Date:  2020-11-19

8.  Late-onset myocardial infarction and autoimmune haemolytic anaemia in a COVID-19 patient without respiratory symptoms, concomitant with a paradoxical increase in inflammatory markers: a case report.

Authors:  Maria Chiara Pelle; Bruno Tassone; Marco Ricchio; Maria Mazzitelli; Chiara Davoli; Giada Procopio; Anna Cancelliere; Valentina La Gamba; Elena Lio; Giovanni Matera; Angela Quirino; Giorgio Settimo Barreca; Enrico Maria Trecarichi; Carlo Torti
Journal:  J Med Case Rep       Date:  2020-12-18

9.  Prognostic significance of hemoglobin level and autoimmune hemolytic anemia in SARS-CoV-2 infection.

Authors:  Abdulrahman A Algassim; Assem A Elghazaly; Abdulrahman S Alnahdi; Owais M Mohammed-Rahim; Abdulaziz G Alanazi; Nawaf A Aldhuwayhi; Mashael M Alanazi; Mohammed F Almutairi; Ibrahim M Aldeailej; Najeeb A Kamli; Mahmoud D Aljurf
Journal:  Ann Hematol       Date:  2020-09-12       Impact factor: 3.673

View more
  1 in total

Review 1.  Complement Mediated Hemolytic Anemias in the COVID-19 Era: Case Series and Review of the Literature.

Authors:  Bruno Fattizzo; Raffaella Pasquale; Valentina Bellani; Wilma Barcellini; Austin G Kulasekararaj
Journal:  Front Immunol       Date:  2021-11-25       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.